HERALD OF MEDICINE

Analysis of Labeling Situation of Drug Instructions for Drug Dose Adjustment in Hemodialysis Patients with End-Stage Renal Disease

LI Siyan, SHEN Jianghua, ZENG Yan, QIU Yujie, SHAO Chen, YAN Suying

Herald of Medicine, 2025, 44(3): 491-496. DOI: 10.3870/j.issn.1004-0781.2025.03.029

类别	种数	有该药物透析清除情况		有药物调整方案		有明确药物调整方案
类别	种数	种数	%	种数	%	种数	%
原研药	168	31	18.45	43	25.59	41	24.40
仿制药	762	124	16.27	191	25.06	187	24.54
χ²		0.471		0.021		0.001
P		0.493		0.886		0.970

Tab.1 Original and generic drug instructions on dialysis related information for hemodialysis patients with end-stage renal disease

Other figure/table from this article

Tab.2 Pairwise analysis results of dialysis related information labeling of original and generic drugs with the same generic name for hemodialysis patients 种
Tab.3 Analysis results of dialysis related information labeling of imported drugs and domestic drugs in hemodialysis patients with end-stage renal disease
Tab.4 Pairwise analysis results of dialysis related information labeling for hemodialysis patients of imported and domestic preparations with the same generic name 种
Tab.5 Labeling analysis of dialysis related information in hemodialysis patients in “the dialyzable drugs”and “the non-dialyzable drugs”
Tab.6 Hemodialysis clearance of dialyzable drug instructions in the "non-dialyzable group"
Tab.7 Hemodialysis clearance of non-dialyzable drug instructions in the dialyzable group
Tab.8 Labeling of medication dialysis related information in hemodialysis patients in 930 drug instructions and evidence-based databases
Tab.9 Consistency of drug dialysis related information content in drug instructions and evidence-based databases for hemodialysis patients 种
Tab.10 Drugs with inconsistent dialysis related information between the instructions and evidence-based databases for hemodialysis patients